The failure of Slovakian opposition parties to build a coalition or push through a bill banning verticalisation in healthcare could make a minority sale of Penta Investments's CEE hospital business PHI less likely.
Europe's largest lab groups could both sell in 2020, with Apax appointing Rothschild to explore a sale of Unilabs while Synlab's majority owner Cinven is also weighing up an exit. The sale values including debt could potentially reach €10bn combined.
Nearly a third of all private equity-owned health care businesses in Europe have been held for at least five years, according to the new HBI Deals Pipeline tool. That suggests many private equity houses are struggling to sell on their investments.
Jos Lamers, 55, the man widely seen as the architect of modern-day Unilabs is moving away from a full-time role at the Pan-European lab and imaging platform, HBI can exclusively reveal. So what lies behind the move and who succeeds him as CEO?
HBI can exclusively reveal that multi-national CEE hospital chain Penta has started meeting with investors with a view to selling at least a minority stake, months after it denied the company was for sale. It tells HBI that it wants a partner who can support international expansion plans.
Regulation is key in assessing the viability of for-profit fertility markets, according to a recent report from HBI intelligence written after months of discussion with operators in EMEA. More liberal markets are almost always more attractive markets.
This week we plot three variables showing possible future market potential for for-profit residential elderly care across eleven different countries and three European regions.
Ophthalmology may be a fragmented market, but international chains like Aier and Optegra are emerging. Can national operators build real competitive advantage in largely unconsolidated markets? And if so, how? HBI 2019 drew together CxOs from three large players as former ophthalmologist turned Mansfield Advisor Victor Chua chaired a session to find out more.
Penta CEO Martin Hrezo has told HBI that CEE's largest hospital chain is not being sold, despite strong rumours to the contrary. Is this the full story? Our source says not.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
